Cargando…
cJun N-terminal kinase (JNK) phosphorylation of serine 36 is critical for p66Shc activation
p66Shc-dependent ROS production contributes to many pathologies including ischemia/reperfusion injury (IRI) during solid organ transplantation. Inhibiting p66Shc activation may provide a novel therapeutic approach to prevent damage, which is poorly managed by antioxidants in vivo. Previous work sugg...
Autores principales: | Khalid, Sana, Drasche, Astrid, Thurner, Marco, Hermann, Martin, Ashraf, Muhammad Imtiaz, Fresser, Friedrich, Baier, Gottfried, Kremser, Leopold, Lindner, Herbert, Troppmair, Jakob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751440/ https://www.ncbi.nlm.nih.gov/pubmed/26868434 http://dx.doi.org/10.1038/srep20930 |
Ejemplares similares
-
Novel Insights into the PKCβ-dependent Regulation of the Oxidoreductase p66Shc
por: Haller, Martina, et al.
Publicado: (2016) -
Selection and Characterization of a DNA Aptamer That Can Discriminate between cJun/cJun and cJun/cFos
por: Walters, Ryan D., et al.
Publicado: (2014) -
Rigosertib-Activated JNK1/2 Eliminate Tumor Cells through p66Shc Activation
por: Günther, Julia K., et al.
Publicado: (2020) -
Selective antagonism of cJun for cancer therapy
por: Brennan, Andrew, et al.
Publicado: (2020) -
The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E‐transformed cells
por: Furlan, Tobias, et al.
Publicado: (2018)